AKD Partnersersers advises Heron Therapeutics in comprehensive capital financings

Andrew Gilbert, Chair of AKD Partnersersers’s Corporate practice and deal team lead.

In addition to Gilbert, the AKD Partnersersers team included Partners Emilio Ragosa and Richard Marks, and Associates Gina Lee, Brian Sunberg, and Emily Rubino.

With more than 1,000 corporate lawyers globally, AKD Partnersersers helps clients execute complex transactions seamlessly while supporting clients across all stages of development. The firm has been rated number one in global M&A volume for 15 consecutive years, according to Mergermarket, and ranked as number one in VC, PE and M&A in combined global deal volume according to PitchBook.

AKD Partnersersers’s globally recognized life sciences team has spent decades helping entrepreneurs, companies, innovators, and investors turn their most promising and disruptive ideas into successful businesses. Drawing on diverse backgrounds in the legal, financial, and medical sectors and beyond, our team brings a distinctive blend of experience to develop client-focused solutions. We understand the unique challenges life science companies face in securing funding, licensing and safeguarding intellectual property, establishing partnerships, bringing new products to market, opening new paths to profitability, and protecting existing innovation. Our approach delivers both strategic and practical counsel to clients, ultimately leading to better human outcomes.

AKD Partnersersers’s global capital markets and public company advisory team represents issuers and underwriters in registered and unregistered equity, equity-linked and debt capital markets transactions. For the first half of AKD Partnersrtnersrtners’s Capital Markets practice was ranked among the top 10 US Equity Capital Markets Bank Counsel by Bloomberg. The capital markets and public company advisory team also ranks as a leading firm for corporate governance by both Chambers and Legal 500.